FDA approves first drug to limit frequent waking to urinate - WRCBtv.com | Chattanooga News, Weather & Sports

FDA approves first drug to limit frequent waking to urinate

Posted: Updated:

By LINDA A. JOHNSON
AP Medical Writer

U.S. regulators Friday approved the first drug to reduce nighttime trips to the bathroom.

The treatment is a nasal spray intended for adults who wake up at least twice a night to urinate. The Food and Drug Administration said the spray, called Noctiva, is not approved to treat all causes of frequent nighttime urination, so doctors must determine the cause and best treatment for each person.

Noctiva is approved specifically for a common condition caused by such things as chronic heart failure, poorly controlled diabetes and bladder and prostate problems, as well as some medications.

The nasal spray is used daily about 30 minutes before bedtime. It works by making the kidneys absorb more water, which reduces the amount of urine.

Noctiva carries the FDA's strongest warning, a so-called black box, because the drug can cause dangerously low levels of sodium in the blood. Other side effects include colds, bronchitis, increased blood pressure, dizziness, back pain and nose bleeds.

Before using the spray, patients must undergo testing to confirm they produce excess urine at night.

The treatment was tested for three months in about 1,000 people 50 and older with the condition, called nocturnal polyuria. The half who used Noctiva had more nights with one or no trips to the bathroom, compared to the group that got a dummy nasal spray, according to the FDA.

The active ingredient in Noctiva, desmopressin acetate, is included in some other drugs, including an injected version for bleeding disorders. The FDA said the nasal spray version is the first approved treatment for frequent nighttime urination.

Noctiva was developed by partners Serenity Pharmaceuticals LLC of Milford, Pennsylvania, and Allergan PLC, which is headquartered in Dublin. Allergan could not immediately provide information on the drug's price or when it will be available.

__

Follow Linda A. Johnson at https://twitter.com/LindaJ_onPharma

Copyright 2017 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

WEEKLY CIRCULARS
  • NewsMore>>

  • Opioid treatment gap in Medicare: methadone clinics

    Opioid treatment gap in Medicare: methadone clinics

    Tuesday, April 24 2018 3:56 AM EDT2018-04-24 07:56:11 GMT
    Tuesday, April 24 2018 8:27 AM EDT2018-04-24 12:27:52 GMT
    (AP Photo/Kevin D. Liles, File). FILE - In this March 7, 2017, file photo, the CEO of a methadone clinic holds a 35 mg liquid dose of methadone in Rossville, Ga. The drug is the oldest and most effective of approved medications used to treat opioid add...(AP Photo/Kevin D. Liles, File). FILE - In this March 7, 2017, file photo, the CEO of a methadone clinic holds a 35 mg liquid dose of methadone in Rossville, Ga. The drug is the oldest and most effective of approved medications used to treat opioid add...
    Opioid overdoses killed 1,354 Americans ages 65 and older in 2016, but Medicare doesn't cover the oldest proven treatment for opioid addiction: methadone.More
    Opioid overdoses killed 1,354 Americans ages 65 and older in 2016, but Medicare doesn't cover the oldest proven treatment for opioid addiction: methadone.More
  • For the first time, Facebook spells out what it forbids

    For the first time, Facebook spells out what it forbids

    Tuesday, April 24 2018 5:46 AM EDT2018-04-24 09:46:06 GMT
    Tuesday, April 24 2018 8:26 AM EDT2018-04-24 12:26:37 GMT
    (AP Photo/Richard Drew, File). FILE - In this March 29, 2018, file photo, the logo for Facebook appears on screens at the Nasdaq MarketSite in New York's Times Square. For the first time, Facebook is making public, on Tuesday, April 24, its detailed gu...(AP Photo/Richard Drew, File). FILE - In this March 29, 2018, file photo, the logo for Facebook appears on screens at the Nasdaq MarketSite in New York's Times Square. For the first time, Facebook is making public, on Tuesday, April 24, its detailed gu...
    For the first time, Facebook spells out how it decides whether to delete your posts.More
    For the first time, Facebook spells out how it decides whether to delete your posts.More
  • What the Tech? App of the day Worktime

    What the Tech? App of the day Worktime

    Tuesday, April 24 2018 8:11 AM EDT2018-04-24 12:11:16 GMT
    If you're like most people with a desk job, your smartphone sits on your desk for the entire day. Why not use it when you're not actually using it. This ridiculously simple app sounds worthless but it may be the app you use the most.More
    If you're like most people with a desk job, your smartphone sits on your desk for the entire day. Why not use it when you're not actually using it. This ridiculously simple app sounds worthless but it may be the app you use the most.More
Powered by Frankly